Loading provider…
Loading provider…
Hematology & Oncology Physician in Saint Augustine, FL
NPI: 1265429989Primary Practice Location
FLAGLER HOSPITAL
400 Health Park Blvd, St Augustine, FL
Primary Employer
Cancer Specialists of North Florida
cancerspecialistsnf.com
HQ Phone
Get MD Marc's Phone Numberphone_androidMobile
Get MD Marc's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1997 - 2027
NC State Medical License
1994 - 2022

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Duke University Hospital
Fellowship • Hematology and Medical Oncology
1994 - 1997
Residency • Internal Medicine
1991 - 1994
McGovern Medical School
med.uth.edu
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 652 | 1,984 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 627 | 1,949 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 357 | 583 |
| 4 | Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 317 | 51,950 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 284 | 536 |
Authors: Luis Chu
Journal: Cancer
A review of hereditary breast cancer: from screening to risk factor modification.
Authors: Warmuth, M A, Sutton, L M, Winer, E P
Journal: Am J Med
Phase I study of Doxil and vinorelbine in metastatic breast cancer.
Authors: Burstein, H J, Ramirez, M J, Petros, W P, Clarke, K D, Warmuth, M A, Marcom, P K, Matulonis, U A, Parker, L M, Harris, L N, Winer, E P
Journal: Ann Oncol
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: rituximab, DRUG: brentuximab vedotin